Style | Citing Format |
---|---|
MLA | Rajabi MT, et al.. "External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction." Middle East African Journal of Ophthalmology, vol. 29, no. 1, 2022, pp. 1-6. |
APA | Rajabi MT, Shahraki K, Mohammadi SS, Nozare A, Moravej Z, Tavakolizadeh S, Salim RE, Hosseinzadeh F, Farahi A, Shahraki K (2022). External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction. Middle East African Journal of Ophthalmology, 29(1), 1-6. |
Chicago | Rajabi MT, Shahraki K, Mohammadi SS, Nozare A, Moravej Z, Tavakolizadeh S, Salim RE, Hosseinzadeh F, Farahi A, Shahraki K. "External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction." Middle East African Journal of Ophthalmology 29, no. 1 (2022): 1-6. |
Harvard | Rajabi MT et al. (2022) 'External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction', Middle East African Journal of Ophthalmology, 29(1), pp. 1-6. |
Vancouver | Rajabi MT, Shahraki K, Mohammadi SS, Nozare A, Moravej Z, Tavakolizadeh S, et al.. External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction. Middle East African Journal of Ophthalmology. 2022;29(1):1-6. |
BibTex | @article{ author = {Rajabi MT and Shahraki K and Mohammadi SS and Nozare A and Moravej Z and Tavakolizadeh S and Salim RE and Hosseinzadeh F and Farahi A and Shahraki K}, title = {External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction}, journal = {Middle East African Journal of Ophthalmology}, volume = {29}, number = {1}, pages = {1-6}, year = {2022} } |
RIS | TY - JOUR AU - Rajabi MT AU - Shahraki K AU - Mohammadi SS AU - Nozare A AU - Moravej Z AU - Tavakolizadeh S AU - Salim RE AU - Hosseinzadeh F AU - Farahi A AU - Shahraki K TI - External Versus Endoscopic Dacryocystorhinostomy for Primary Acquired Nasolacrimal Duct Obstruction JO - Middle East African Journal of Ophthalmology VL - 29 IS - 1 SP - 1 EP - 6 PY - 2022 ER - |